SCHEMBL4575200

SCHEMBL4575200

CCOC(=O)C(C)(C)Oc1ccc(CCNCc2ccc(C(F)(F)F)cc2)cc1OC

nearest known ligand 0.56

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.56
TDP1 Q9NUW8 1/20 0.56
ALDH1A1 P00352 2/20 0.49
GLA P06280 1/20 0.49
PPARA Q07869 11/20 0.48
PPARD Q03181 5/20 0.48
PPARG P37231 5/20 0.46
MEN1 O00255 1/20 0.46
KMT2A Q03164 1/20 0.46
PSEN1 P49768 2/20 0.45
PSEN2 P49810 2/20 0.45
APH1B Q8WW43 2/20 0.45
NCSTN Q92542 2/20 0.45
APH1A Q96BI3 2/20 0.45
PSENEN Q9NZ42 2/20 0.45
TMEM97 Q5BJF2 1/20 0.45
PTGDR2 Q9Y5Y4 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4575193 0.88 KDM4E (0.45) KDM4ETDP1PPARAPPARDPPARG
SCHEMBL4575310 0.83 PPARA (0.50) ALDH1A1PPARAPPARDPPARGMEN1
SCHEMBL4109056 0.82 KDM4E (0.71) KDM4ETDP1ALDH1A1GLAMEN1
SCHEMBL5648539 0.81 PPARA (0.48) PPARAPPARDPPARG
SCHEMBL5187722 0.77 PPARA (0.49) PPARAPPARDPPARG
SCHEMBL4576063 0.76 PPARA (0.50) KDM4ETDP1ALDH1A1PPARAPPARD
SCHEMBL6582598 0.75 PPARA (0.63) ALDH1A1PPARAPPARDPPARG
SCHEMBL14144766 0.75 PPARA (0.45) KDM4EALDH1A1PPARAPPARG
SCHEMBL4575602 0.75 PPARA (0.52) ALDH1A1PPARAPPARGMEN1KMT2A
SCHEMBL4575439 0.74 KDM4E (0.55) KDM4ETDP1ALDH1A1GLAPPARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7319104-B2 hPPARs activators SMITHKLINE BEECHAM CORPORATION (US) 2008-01-15 US disclosed
US-7319104-B2 hPPARs activators SMITHKLINE BEECHAM CORPORATION (US) 2008-01-15 US disclosed
US-7319104-B2 hPPARs activators SMITHKLINE BEECHAM CORPORATION (US) 2008-01-15 US disclosed
US-20050137212-A1 Hppars activators SMITHKLINE BEECHAM CORPORATION 2005-06-23 US disclosed
EP-1480957-A1 HPPARS ACTIVATORS SMITHKLINE BEECHAM CORPORATION (US) 2004-12-01 EP disclosed
WO-2003074495-A1 HPPARS ACTIVATORS SMITHKLINE BEECHAM CORPORATION (US) 2003-09-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050137212-A1 Hppars activators PPARG, PPARA, PPARD KDM4E 4112/4885TDP1 2710/4885ALDH1A1 645/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.